carbidopa
Quick Summary
Carbidopa is a drug used in combination with levodopa to treat Parkinson's disease. Parkinson's disease is characterized by a deficiency of dopamine, a neurotransmitter crucial for movement. Levodopa is a precursor to dopamine, but it is often broken down in the body before it can reach the brain.123
Carbidopa works by inhibiting the enzyme that breaks down levodopa outside of the brain. This allows more levodopa to be available for transport into the brain, where it can be converted into dopamine. By increasing the amount of levodopa that reaches the brain, carbidopa helps to increase the effectiveness of levodopa therapy and reduce the risk of side effects.13
Ask Britannica AI about this topic
Britannica doesn't have a full article on this topic, so we've curated a list of our relevant coverage.
- Parkinson diseaseTreatment
Cotreatment with a drug called carbidopa, which inhibits an enzyme that breaks down levodopa prior to crossing the blood-brain barrier, allows higher concentrations of levodopa to reach the brain. Thus, levodopa-carbidopa combination therapy enables lower doses of levodopa to be administered, thereby reducing side effects. This combination therapy has allowed…
Read MoreCotreatment with a drug called carbidopa, which inhibits an enzyme that breaks down levodopa prior to crossing the blood-brain barrier, allows higher concentrations of levodopa to reach the brain. Thus, levodopa-carbidopa combination therapy enables lower doses of levodopa to be administered, thereby reducing side effects. This combination therapy has allowed…
Read More - antiparkinson drugLevodopa
…levodopa therapy is supplemented with carbidopa (an analog of levodopa), which inhibits the decarboxylation (and hence breakdown) of levodopa to dopamine prior to crossing the blood-brain barrier (dopamine itself cannot penetrate the blood-brain barrier). As a result, greater amounts of levodopa are able to reach the brain, enabling the administration…
Read More…levodopa therapy is supplemented with carbidopa (an analog of levodopa), which inhibits the decarboxylation (and hence breakdown) of levodopa to dopamine prior to crossing the blood-brain barrier (dopamine itself cannot penetrate the blood-brain barrier). As a result, greater amounts of levodopa are able to reach the brain, enabling the administration…
Read More